UNSPSC 51152069: Rapacuronium bromide

This classification denotes a muscle relaxant with the molecular formula C37H61N2O4.Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 65Q4QDG4KC, chemically known as piperidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-3-(acetyloxy)-17-(1-oxopropoxy)-2-(1-piperidinyl)androstan-16-yl)-1-(2-propenyl)-, bromide but more generally known as rapacuronium bromide, which bears US NIH Compound Identifier 177969.

UNSPSC 51152069 Rapacuronium bromide is a Commodity code that, based on recent state and local solicitation activity, does not align with actual procurement under this designation. The single recent opportunity tagged to this code — Seminole County, Florida's IFB 60459723LAS — solicits naloxone and drug deactivation systems, which are distinct pharmaceutical products and harm-reduction equipment unrelated to rapacuronium bromide, a neuromuscular blocking agent used in anesthesia. The mismatch suggests either a tagging error in the opportunity record or a misalignment between the code's intended scope and how state and local procurement systems are deploying it. State and local governments do not appear to be actively procuring rapacuronium bromide through open competitive processes at this time.

Seminole County's naloxone procurement represents the only recent activity in the opportunity block. The county issued the IFB on June 30, 2026, with a response deadline of July 26, 2023 (the date field contains an apparent data inconsistency), seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually on a two-year contract with a one-year renewal option. Deliveries are to the Seminole County Community Health Building in Sanford, Florida, with vendors responsible for all shipping costs. The procurement requires drug-free workplace certification, E-Verify compliance, and standard commercial insurance; potential FEMA funding introduces federal compliance overlays including the Clean Air Act and Federal Water Pollution Control Act. No explicit set-aside designations or budget ranges are stated. The code shows no other recent state or local opportunities, and the single example does not support meaningful geographic or issuing-body characterization for rapacuronium bromide procurement.